Global Assisted Reproductive Technologies Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Assisted Reproductive Technologies Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.
Assisted Reproductive Technologies Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Assisted Reproductive Technologies Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Specialty & Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Assisted Reproductive Technologies Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Assisted Reproductive Technologies Drugs key companies include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc. Merck, MSD, Ipsen are top 3 players and held % share in total in 2022.
Assisted Reproductive Technologies Drugs can be divided into Down-Regulation Drugs, Ovulation Stimulation Drugs, Ovulation Inducing Drugs and Luteal Support Medications, etc. Down-Regulation Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Assisted Reproductive Technologies Drugs is widely used in various fields, such as Hospital Pharmacy, Specialty & Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Assisted Reproductive Technologies Drugs industry development. In 2022, global % share of Assisted Reproductive Technologies Drugs went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Assisted Reproductive Technologies Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Merck
MSD
Ipsen
Ferring
Organon
Solvay
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Down-Regulation Drugs
Ovulation Stimulation Drugs
Ovulation Inducing Drugs
Luteal Support Medications
Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Assisted Reproductive Technologies Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Assisted Reproductive Technologies Drugs introduction, etc. Assisted Reproductive Technologies Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Assisted Reproductive Technologies Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Assisted Reproductive Technologies Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Assisted Reproductive Technologies Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Specialty & Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Assisted Reproductive Technologies Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Assisted Reproductive Technologies Drugs key companies include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc. Merck, MSD, Ipsen are top 3 players and held % share in total in 2022.
Assisted Reproductive Technologies Drugs can be divided into Down-Regulation Drugs, Ovulation Stimulation Drugs, Ovulation Inducing Drugs and Luteal Support Medications, etc. Down-Regulation Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Assisted Reproductive Technologies Drugs is widely used in various fields, such as Hospital Pharmacy, Specialty & Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Assisted Reproductive Technologies Drugs industry development. In 2022, global % share of Assisted Reproductive Technologies Drugs went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Assisted Reproductive Technologies Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck
MSD
Ipsen
Ferring
Organon
Solvay
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Down-Regulation Drugs
Ovulation Stimulation Drugs
Ovulation Inducing Drugs
Luteal Support Medications
Segment by Application
Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Assisted Reproductive Technologies Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Assisted Reproductive Technologies Drugs introduction, etc. Assisted Reproductive Technologies Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Assisted Reproductive Technologies Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices